Hexoprenaline: Difference between revisions

Jump to navigation Jump to search
m (Protected "Hexoprenaline": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 31: Line 31:
{{CMG}}
{{CMG}}


{{EH}}
 


'''Hexoprenaline''' ([[International Nonproprietary Name|INN]]) is a [[Beta-2 adrenergic receptor|β2-adrenergic receptor]] [[agonist]] used in the treatment of [[asthma]].<ref>Pinder RM, Brogden RN, Speight TM, Avery GS. Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. ''Drugs''. 1977 Jul;14(1):1-28. PMID 195789</ref>
'''Hexoprenaline''' ([[International Nonproprietary Name|INN]]) is a [[Beta-2 adrenergic receptor|β2-adrenergic receptor]] [[agonist]] used in the treatment of [[asthma]].<ref>Pinder RM, Brogden RN, Speight TM, Avery GS. Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. ''Drugs''. 1977 Jul;14(1):1-28. PMID 195789</ref>

Revision as of 15:58, 9 August 2012

Hexoprenaline
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H32N2O6
Molar mass420.499 g/mol
3D model (JSmol)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]

References

  1. Pinder RM, Brogden RN, Speight TM, Avery GS. Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. Drugs. 1977 Jul;14(1):1-28. PMID 195789


Template:WH Template:WS